Skip to content
Assyro AI
FDA 483 Database

FDA Form 483s Issued in May 2023

Every published Form FDA 483 issued in May 2023, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

9

Published 483s in May 2023

9

Distinct firms

Form 483s issued in May 2023

  • Sanofi S.r.l.FDA
    FEI
    3002807108
    Record date
    Establishment
    Drug Manufacturer
    Location
    Italy
  • Laboratorios Farmaceuticos Rovi S. A.FDA
    FEI
    3010705046
    Record date
    Establishment
    Sterile Drug Manufacturer
    Location
    Spain
  • Wuxi Biologics Co LtdFDA
    FEI
    3010606982
    Record date
    Establishment
    Active Pharmaceutical Ingredient Manufacturer
    Location
    China
  • Patheon Italia S.p.A.FDA
    FEI
    3003065803
    Record date
    Establishment
    Finished Pharmaceutical Manufacturer
    Location
    Italy
  • Apicore Pharmaceuticals Private LtdFDA
    FEI
    3006767695
    Record date
    Establishment
    Human Drug Manufacturer
    Location
    India
  • Medi-Fare DrugFDA
    FEI
    3009925820
    Record date
    Establishment
    Outsourcing Facility
    Location
    South Carolina, United States
  • SCA Pharmaceuticals, Inc.FDA
    FEI
    3010683157
    Record date
    Establishment
    Outsourcing Facility
    Location
    Arkansas, United States
  • Catalent Indiana, LLCFDA
    FEI
    3005949964
    Record date
    Establishment
    Finished Pharmaceutical Manufacturer
    Location
    United States
  • Intas Pharmaceuticals LimitedFDA
    FEI
    3003157498
    Record date
    Establishment
    Human Drug Manufacturer
    Location
    India

Other months in 2023

Back to the FDA 483 Database